NO20053595L - Escitalopramdibromid samt fremgangsmate ved fremstilling derav. - Google Patents

Escitalopramdibromid samt fremgangsmate ved fremstilling derav.

Info

Publication number: NO20053595L
Authority: NO; Norway
Prior art keywords: escitalopram; dibromide; citalopram; hydrobromide; processes
Prior art date: 2002-12-23

Application number

NO20053595A

Other languages

English (en)

Norwegian (no)

Inventor

Hans Petersen

Peter Ellegaard

Robert Dancer

Lawrence Martel

Original Assignee

Lundbeck & Co As H

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-12-23

Filing date

2005-07-25

Publication date

2005-09-05

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32668635&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20053595(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-07-25 Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H

2005-09-05 Publication of NO20053595L publication Critical patent/NO20053595L/no

Links

WSEQXVZVJXJVFP-FQEVSTJZSA-N escitalopram Chemical compound C1([C@]2(C3=CC=C(C=C3CO2)C#N)CCCN(C)C)=CC=C(F)C=C1 WSEQXVZVJXJVFP-FQEVSTJZSA-N 0.000 title abstract 2
229960004341 escitalopram Drugs 0.000 title abstract 2
CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 abstract 1
229960001653 citalopram Drugs 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Epidemiology (AREA)
Addiction (AREA)
Reproductive Health (AREA)
Psychology (AREA)
Child & Adolescent Psychology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Hospice & Palliative Care (AREA)
Nutrition Science (AREA)
Pain & Pain Management (AREA)
Endocrinology (AREA)
Anesthesiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

NO20053595A 2002-12-23 2005-07-25 Escitalopramdibromid samt fremgangsmate ved fremstilling derav. NO20053595L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DKPA200202005		2002-12-23
PCT/DK2003/000902 WO2004056791A1 (en)	2002-12-23	2003-12-18	Escitalopram hydrobromide and a method for the preparation thereof

Publications (1)

Publication Number	Publication Date
NO20053595L true NO20053595L (no)	2005-09-05

Family

ID=32668635

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20053595A NO20053595L (no)	2002-12-23	2005-07-25	Escitalopramdibromid samt fremgangsmate ved fremstilling derav.

Country Status (32)

Country	Link
US (1)	US20040167209A1 (de)
EP (1)	EP1578738B1 (de)
JP (2)	JP4658613B2 (de)
KR (1)	KR20050086933A (de)
CN (1)	CN100349885C (de)
AR (1)	AR042652A1 (de)
AT (1)	ATE388947T1 (de)
AU (1)	AU2003287919B2 (de)
BR (1)	BR0317623A (de)
CA (1)	CA2511142A1 (de)
CY (1)	CY1107451T1 (de)
DE (1)	DE60319739T2 (de)
DK (1)	DK1578738T3 (de)
EA (1)	EA013116B1 (de)
EG (1)	EG24729A (de)
ES (1)	ES2298595T3 (de)
IL (1)	IL169125A0 (de)
IS (1)	IS2654B (de)
ME (1)	MEP5808A (de)
MX (1)	MXPA05005772A (de)
MY (1)	MY135468A (de)
NO (1)	NO20053595L (de)
NZ (1)	NZ540281A (de)
PE (1)	PE20040924A1 (de)
PL (1)	PL378275A1 (de)
PT (1)	PT1578738E (de)
RS (1)	RS51092B (de)
TW (1)	TW200501943A (de)
UA (1)	UA80170C2 (de)
UY (1)	UY28148A1 (de)
WO (1)	WO2004056791A1 (de)
ZA (1)	ZA200504109B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20050137255A1 (en) *	2002-12-23	2005-06-23	H. Lundbeck A/S	Crystalline escitalopram hydrobromide and methods for preparing the same
CN100349885C (zh) *	2002-12-23	2007-11-21	H·隆德贝克有限公司	依他普仑氢溴酸盐及其制备方法
BRPI0508266A (pt) *	2004-03-05	2007-07-31	Lundbeck & Co As H	partìculas cristalinas de oxalato de escitalopram, forma de dosagem única sólida, e, métodos para a fabricação de partìculas cristalinas de oxalato de escitalopram e para reduzir a quantidade de hidroxila que contém impurezas no citalopram, escitalopram ou uma mistura não racêmica de r- e s-citalopram
US7834201B2 (en)	2005-06-22	2010-11-16	H. Lundbeck A/S	Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
TWI347942B (en)	2005-06-22	2011-09-01	Lundbeck & Co As H	Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
ZA200804086B (en) *	2005-10-14	2009-07-29	Lundbeck & Co As H	Stable pharmaceutical formulations containing escitalo-pram and bupropion
EP1954257A4 (de) *	2005-10-14	2009-05-20	Lundbeck & Co As H	Verfahren zur behandlung von erkrankungen des zentralen nervensystems mit einer niedrigdosierten kombination aus escitalopram und bupropion
TW200812993A (en) *	2006-05-02	2008-03-16	Lundbeck & Co As H	New uses of escitalopram
WO2008007691A1 (en) *	2006-07-11	2008-01-17	Mitsubishi Tanabe Pharma Corporation	Salt of morpholine compound
WO2008059514A2 (en) *	2006-07-31	2008-05-22	Cadila Healthcare Limited	Process for preparing escitalopram
FR3006594A1 (fr) *	2013-06-11	2014-12-12	Sorin Crm Sas	Microsonde implantable de detection/stimulation incorporant un agent anti-inflammatoire
CN108976188B (zh) *	2017-06-05	2022-12-06	上海奥博生物医药股份有限公司	一种艾司西酞普兰双羟萘酸盐新的制备方法
AU2018349284B2 (en) *	2017-10-09	2023-11-16	428 Pharma BV.	New salt and solid state forms of escitalopram
WO2022153262A1 (en)	2021-01-18	2022-07-21	Anton Frenkel	Pharmaceutical dosage form

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US34712A (en) *		1862-03-18		James h
GB1526331A (en) *	1976-01-14	1978-09-27	Kefalas As	Phthalanes
GB8419963D0 (en) *	1984-08-06	1984-09-12	Lundbeck & Co As H	Intermediate compound and method
GB8814057D0 (en) *	1988-06-14	1988-07-20	Lundbeck & Co As H	New enantiomers & their isolation
PL199423B1 (pl) *	1998-10-20	2008-09-30	Lundbeck & Co As H	Sposób wytwarzania citalopramu
AR021155A1 (es) *	1999-07-08	2002-06-12	Lundbeck & Co As H	Tratamiento de desordenes neuroticos
EP1298124B1 (de) *	1999-10-25	2007-02-28	H. Lundbeck A/S	Verfahren zur Herstellung von Citalopram
US6977306B2 (en) *	2000-05-02	2005-12-20	Sumitomo Chemical Company, Limited	Citalopram hydrobromide crystal and method for crystallization thereof
JP2002020379A (ja) *	2000-05-02	2002-01-23	Sumika Fine Chemicals Co Ltd	シタロプラム臭化水素酸塩の結晶およびその結晶化方法
CA2353693C (en) *	2000-08-10	2003-07-22	H. Lundbeck A/S	Pharmaceutical composition containing citalopram
CA2430146C (en) *	2000-12-04	2011-02-15	Dr. Frische Gmbh	Method for the production of fatty acid esters
EA200301195A1 (ru) *	2001-05-01	2004-04-29	Х. Лундбекк А/С	Применение энантиомерно чистого эсциталопрама
AR034612A1 (es) *	2001-06-25	2004-03-03	Lundbeck & Co As H	Proceso para la preparacion del citalopram racemico y/o del s- o r-citalopram mediante la separacion de una mezcla de r- y s-citalopram
CN100349885C (zh) *	2002-12-23	2007-11-21	H·隆德贝克有限公司	依他普仑氢溴酸盐及其制备方法
US20050174782A1 (en) *	2003-03-25	2005-08-11	Chapman Leonard T.	Flashlight

2003
- 2003-12-18 CN CNB2003801063775A patent/CN100349885C/zh not_active Expired - Fee Related
- 2003-12-18 PL PL378275A patent/PL378275A1/pl not_active Application Discontinuation
- 2003-12-18 KR KR1020057011704A patent/KR20050086933A/ko not_active Ceased
- 2003-12-18 CA CA002511142A patent/CA2511142A1/en not_active Abandoned
- 2003-12-18 DE DE60319739T patent/DE60319739T2/de not_active Expired - Lifetime
- 2003-12-18 EA EA200501046A patent/EA013116B1/ru not_active IP Right Cessation
- 2003-12-18 ES ES03779759T patent/ES2298595T3/es not_active Expired - Lifetime
- 2003-12-18 ME MEP-58/08A patent/MEP5808A/xx unknown
- 2003-12-18 AU AU2003287919A patent/AU2003287919B2/en not_active Ceased
- 2003-12-18 AT AT03779759T patent/ATE388947T1/de not_active IP Right Cessation
- 2003-12-18 NZ NZ540281A patent/NZ540281A/en not_active Application Discontinuation
- 2003-12-18 JP JP2004561083A patent/JP4658613B2/ja not_active Expired - Lifetime
- 2003-12-18 EP EP03779759A patent/EP1578738B1/de not_active Expired - Lifetime
- 2003-12-18 UA UAA200506077A patent/UA80170C2/uk unknown
- 2003-12-18 BR BR0317623-1A patent/BR0317623A/pt not_active IP Right Cessation
- 2003-12-18 RS YUP-2005/0487A patent/RS51092B/sr unknown
- 2003-12-18 DK DK03779759T patent/DK1578738T3/da active
- 2003-12-18 PT PT03779759T patent/PT1578738E/pt unknown
- 2003-12-18 WO PCT/DK2003/000902 patent/WO2004056791A1/en not_active Ceased
- 2003-12-18 MX MXPA05005772A patent/MXPA05005772A/es active IP Right Grant
- 2003-12-22 MY MYPI20034949A patent/MY135468A/en unknown
- 2003-12-22 AR ARP030104777A patent/AR042652A1/es unknown
- 2003-12-22 TW TW092136380A patent/TW200501943A/zh unknown
- 2003-12-23 UY UY28148A patent/UY28148A1/es not_active Application Discontinuation
- 2003-12-23 US US10/746,913 patent/US20040167209A1/en not_active Abandoned
2004
- 2004-01-05 PE PE2004000013A patent/PE20040924A1/es not_active Application Discontinuation
2005
- 2005-05-17 IS IS7848A patent/IS2654B/is unknown
- 2005-05-20 ZA ZA200504109A patent/ZA200504109B/en unknown
- 2005-06-09 IL IL169125A patent/IL169125A0/en unknown
- 2005-06-22 EG EGNA2005000345 patent/EG24729A/xx active
- 2005-07-25 NO NO20053595A patent/NO20053595L/no not_active Application Discontinuation
2008
- 2008-05-02 CY CY20081100470T patent/CY1107451T1/el unknown
2010
- 2010-10-20 JP JP2010235287A patent/JP2011037893A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
DE60319739T2 (de)	2008-07-17
MY135468A (en)	2008-04-30
AR042652A1 (es)	2005-06-29
BR0317623A (pt)	2005-11-29
DE60319739D1 (de)	2008-04-24
AU2003287919B2 (en)	2009-11-12
AU2003287919A1 (en)	2004-07-14
UY28148A1 (es)	2004-09-30
ZA200504109B (en)	2006-08-30
CN100349885C (zh)	2007-11-21
WO2004056791A1 (en)	2004-07-08
IL169125A0 (en)	2009-02-11
EA013116B1 (ru)	2010-02-26
RS51092B (sr)	2010-10-31
RS20050487A (sr)	2007-06-04
PE20040924A1 (es)	2004-12-11
US20040167209A1 (en)	2004-08-26
ES2298595T3 (es)	2008-05-16
EG24729A (en)	2010-06-21
IS7848A (is)	2005-05-17
DK1578738T3 (da)	2008-06-30
JP2011037893A (ja)	2011-02-24
MXPA05005772A (es)	2005-08-16
ATE388947T1 (de)	2008-03-15
EA200501046A1 (ru)	2005-12-29
CN1726202A (zh)	2006-01-25
HK1087708A1 (en)	2006-10-20
JP4658613B2 (ja)	2011-03-23
JP2006514952A (ja)	2006-05-18
KR20050086933A (ko)	2005-08-30
MEP5808A (xx)	2010-02-10
UA80170C2 (en)	2007-08-27
EP1578738A1 (de)	2005-09-28
IS2654B (is)	2010-08-15
NZ540281A (en)	2008-07-31
PT1578738E (pt)	2008-04-11
TW200501943A (en)	2005-01-16
EP1578738B1 (de)	2008-03-12
CA2511142A1 (en)	2004-07-08
CY1107451T1 (el)	2012-12-19
PL378275A1 (pl)	2006-03-20

Legal Events

Date	Code	Title	Description
2008-07-14	CREP	Change of representative	Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104
2011-07-25	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
MY142777A (en)	2010-12-31	Substituted indole-o-glucosides
CL2004001174A1 (es)	2005-05-06	Composicion farmaceutica que comprende: 1-(4-fluorofenil)-3(r)-[3-(4-fluorofenil)-3(s)-hidroxipropil]-4(s)-(4-hidroxifenil)-2-acetidinona (ezetimiba) y excipientes; y su uso en el tratamiento y/o prevencion de aterosclerosis, hipercolesterolemia, dia
UA86042C2 (en)	2009-03-25	Substituted indazole-o-glucosides
CY1107451T1 (el)	2012-12-19	Υδροβρωμικον escitalopram και μεθοδος δια την παρασκευη αυτου
WO2005011592A3 (en)	2005-06-16	Substituted indazole-o-glucosides
SE0100901D0 (sv)	2001-03-15	New composition
DE60022692D1 (de)	2005-10-20	(S,S)-Reboxetin zur Behandlung von Migränekopfschmerzen
MXPA03010134A (es)	2004-03-10	Derivados de ciclohexan-1-4-diamina sustituidos.
NO20060402L (no)	2006-04-06	3-amino choman og 2-aminotetralinderivater
BRPI0414599A (pt)	2006-11-07	pirrol-indóis substituìdos
NO20070391L (no)	2007-03-20	Jernsulfatbasert fosfatadsorbent
GB0216001D0 (en)	2002-08-21	Process and composition
DK1465641T3 (da)	2007-11-19	Lægemidler indeholdende deuterium til behandling af sukkersyge
HU229456B1 (en)	2013-12-30	Aminoalkylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
NO20041200L (no)	2004-03-23	Fremgangsmate for fremstilling av citalopram.
NO20031648L (no)	2003-06-04	Farmasöytiske lösninger av modafinilforbindelser
MXPA03007635A (es)	2003-12-04	P-tienilbencilamidas que sirven como agonistas de receptores para angiotensina-(1-7), metodo para su produccion, su uso y preparaciones farmaceuticas que las contienen.
WO2004099388A3 (en)	2007-11-22	Cbl-b polypeptides, complexes and related methods
NO331195B1 (no)	2011-10-31	Fremgangsmate for fremstilling av halogen-substituerte monosulfider og deres hydroksymonosulfid-evkivalenter som mellomprodukter.
NO20033318D0 (no)	2003-07-23	2H-1-benzopyranderivater, fremgangsmåte ved fremstilling samt farmasöytiskesammensetninger derav
JP2004500380A5 (de)	2006-01-05
NO20023150L (no)	2002-06-28	Fremgangsmate for fremstilling av citalopram
MY149864A (en)	2013-10-31	Flavouring-containing pharmaceutical formulations with improved pharmaceutical properties
TR200402030T4 (tr)	2004-09-21	İkame edilen I-aminobutan-3-ol-türevleri
ITRM20000266A0 (it)	2000-05-17	Procedimento migliorato per la preparazione di (e,z) 3-(2-amminoetossimmino)-androstano-6, 17-dione e di suoi analoghi.